Thursday, July 13, 2017

Watch - Individualizing Initial HCV Therapy

Watch - Individualizing Initial HCV Therapy

New over at Clinical Care Options, Tram T. Tran MD, Kristen Marks MD, Nancy Reau MD, FAASLD, AGAF, and Norah Terrault MD, MPH discuss "Individualizing Initial HCV Therapy" using a case-presentation format:
Led by Tram T. Tran, MD, a panel of experts discusses their approach to individualizing initial HCV therapy based on key disease and patient characteristics that have an impact on treatment choice, including HCV genotype, race, cirrhosis, comorbidities, and comedications.
Free Registration Is Required
If you are not registered at CCO, click here to begin the process.

All Video Modules
July 05, 2017
Led by Nancy Reau, MD, FAASLD, AGAF, a panel of experts discuss their approach to management of viral hepatitis in challenging clinical scenarios.

July 12, 2017
Experts discusses their approach to individualizing initial HCV therapy based on key disease and patient characteristics that have an impact on treatment choice, including HCV genotype, race, cirrhosis, comorbidities, and comedications.

Downloadable Slidesets 
In this downloadable slideset, Ira M. Jacobson, MD, and Norah Terrault, MD, MPH, provide a comprehensive update on current and near-future HCV management.

In this downloadable slideset, David L. Wyles, MD, provides a comprehensive overview of available data and guideline recommendations on retreatment of HCV infection in patients who experienced previous DAA failure.

Source -  CCO
Follow On Twitter - @CCO_Hepatitis

No comments:

Post a Comment